bispecific antibodies

Pharma

China's BCI nod, AZ, Astellas—Fierce Pharma Asia

China approved the world's first commercial brain-computer interface. AZ expands cell therapy capabilities in China. Astellas ended a bispecific deal.

Angus Liu Mar 20, 2026 8:00am

Kyowa, Sino Biopharm, Duality—Fierce Pharma Asia

Mar 6, 2026 9:35am

China deal growth, Daiichi CMO, Astellas-Vir—Fierce Pharma Asia

Feb 27, 2026 9:50am

Bristol Myers CEO pledges to 'cast a broad net' in dealmaking

Jan 12, 2026 4:28pm

China biotech deals, Shionogi's ALS buy—Fierce Pharma Asia

Jan 9, 2026 3:00am

Roche's bispecific Lunsumio goes subcutaneous

Dec 22, 2025 10:15am